---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-002723"
form_type: "8-K"
ticker: "BCDA"
cik: "0000925741"
company_name: "BioCardia, Inc."
filed_at: "2026-02-03T23:59:59+00:00"
generated_at: "2026-05-16T05:31:11.120223+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BioCardia announces acceptance of CardiAMP HF echocardiography data for late-breaking presentation at THT 2026

## Summary
- Echocardiography data from CardiAMP HF trial accepted for Late Breaking Clinical Trial Oral Presentation at THT Meeting.
- Presentation by Dr. Amish Raval, Professor of Medicine at UW School of Medicine and Public Health and CardiAMP HF National Co-PI.
- THT meeting takes place March 2-4, 2026 in Boston, MA.
- Title: 'Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics.'

## SEC filing metadata
- accession: 0001437749-26-002723
- form_type: 8-K
- ticker: BCDA
- cik: 0000925741
- company_name: BioCardia, Inc.
- filed_at: 2026-02-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/925741/000143774926002723/0001437749-26-002723-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/925741/000143774926002723/bcda20260203_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-002723
- JSON: https://secwatch.observer/filing/0001437749-26-002723.json
- Plain text: https://secwatch.observer/filing/0001437749-26-002723.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.